Contribution of FAT/CD36 to the regulation of skeletal muscle fatty acid oxidation: an overview
- 11 November 2008
- journal article
- review article
- Published by Wiley in Acta Physiologica
- Vol. 194 (4), 293-309
- https://doi.org/10.1111/j.1748-1716.2008.01878.x
Abstract
Long chain fatty acids (LCFAs) are an important substrate for ATP production within the skeletal muscle. The process of LCFA delivery from adipose tissue to muscle mitochondria involves many regulatory steps. Recently, it has been recognized that LCFA oxidation is not only dependent on LCFA delivery to the muscle, but also on regulatory steps within the muscle. Increasing selected fatty acid binding proteins/transporters on the plasma membrane facilitates a very rapid LCFA increase into the muscle, independent of any changes in LCFA delivery to the muscle. Such a mechanism of LCFA transporter translocation is activated by muscle contraction. Intramuscular triacylglycerols may also be hydrolysed to provide fatty acids for mitochondrial oxidation, particularly during exercise, when hormone-sensitive lipase and other enzymes are activated. Mitochondrial LCFA entry is also highly regulated. This however does not involve only the malonyl CoA carnitine palmitoyltransferase-I (CPTI) axis. Exercise-induced fatty acid entry into mitochondria is also regulated by at least one of the proteins (FAT/CD36) that also regulates plasma membrane fatty acid transport. Among individuals, differences in mitochondrial fatty acid oxidation appear to be correlated with the content of mitochondrial CPTI and FAT/CD36. This paper provides a brief overview of mechanisms that regulate LCFA uptake and oxidation in skeletal muscle during exercise and in obesity. We focus largely on our own work on FAT/CD36, which contributes to regulating, in a coordinated fashion, LCFA uptake across the plasma membrane and the mitochondrial membrane. Very little is known about the roles of FATP1-6 on fatty acid transport in skeletal muscle.Keywords
This publication has 127 references indexed in Scilit:
- Rosiglitazone increases fatty acid oxidation and fatty acid translocase (FAT/CD36) but not carnitine palmitoyltransferase I in rat muscle mitochondriaThe Journal of Physiology, 2008
- Fatty acid oxidation in cardiac and skeletal muscle mitochondria is unaffected by deletion of CD36Archives of Biochemistry and Biophysics, 2007
- Negligible direct lactate oxidation in subsarcolemmal and intermyofibrillar mitochondria obtained from red and white rat skeletal muscleThe Journal of Physiology, 2007
- Fatty acid binding protein facilitates sarcolemmal fatty acid transport but not mitochondrial oxidation in rat and human skeletal muscleThe Journal of Physiology, 2007
- Patients with type 2 diabetes have normal mitochondrial function in skeletal muscleDiabetologia, 2007
- AMPK-mediated increase in myocardial long-chain fatty acid uptake critically depends on sarcolemmal CD36Biochemical and Biophysical Research Communications, 2007
- FATP1 Is an Insulin-Sensitive Fatty Acid Transporter Involved in Diet-Induced ObesityMolecular and Cellular Biology, 2006
- Signalling components involved in contraction-inducible substrate uptake into cardiac myocytesProceedings Of The Nutrition Society, 2004
- The fatty acid translocase (FAT)/CD36 and the glucose transporter GLUT4 are localized in different cellular compartments in rat cardiac muscleBiochemical and Biophysical Research Communications, 2002
- Membrane Associated Fatty Acid Binding Protein (FABPpm) in Human Skeletal Muscle Is Increased by Endurance TrainingBiochemical and Biophysical Research Communications, 1997